Absci (ABSI) Other Working Capital Changes (2020 - 2026)
Absci's (ABSI) quarterly Other Working Capital Changes came in at $862000.0 in Q1 2026, up 4410.0% year-on-year from $19113.1 in Q1 2025, and up 17.76% quarter-over-quarter from $732000.0 in Q4 2025.
Absci (ABSI) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Absci has disclosed Other Working Capital Changes across 7 years of filings, most recently posting $862000.0 for Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at $862000.0, up 4410.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (down 4.11% YoY), and the FY2025 annual result was $424000.0, down 12.4% from the prior year.
- Other Working Capital Changes came in at $862000.0 for Q1 2026 at Absci, up from $732000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $3.5 million in Q3 2024 to a low of -$3.2 million in Q4 2022.
- The 5-year median for Other Working Capital Changes is -$277000.0 (2023), against an average of -$16352.9.
- Across the five-year window, Other Working Capital Changes tumbled 361.01% in 2022 and jumped 4410.0% in 2026, its largest moves.
- Absci's Other Working Capital Changes stood at -$3.2 million in 2022, then surged by 155.46% to $1.8 million in 2023, then tumbled by 146.6% to -$836000.0 in 2024, then jumped by 187.56% to $732000.0 in 2025, then advanced by 17.76% to $862000.0 in 2026.
- The last three Other Working Capital Changes figures came in at $862000.0 (Q1 2026), $732000.0 (Q4 2025), and -$189000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 862,000.00 |
| Mar 31, 2026 | 862,000.00 |
| Dec 31, 2025 | 732,000.00 |
| Dec 31, 2025 | 732,000.00 |
| Sep 30, 2025 | -189,000.00 |
| Sep 30, 2025 | -189,000.00 |
| Jun 30, 2025 | -99,000.00 |
| Jun 30, 2025 | -99,000.00 |
| Mar 31, 2025 | -20,000.00 |
| Mar 31, 2025 | -20,000.00 |
| Dec 31, 2024 | -836,000.00 |
| Dec 31, 2024 | -836,000.00 |
| Sep 30, 2024 | 3.49 Mn |
| Sep 30, 2024 | 3.49 Mn |
| Jun 30, 2024 | -1.27 Mn |
| Jun 30, 2024 | -1.27 Mn |
| Mar 31, 2024 | -898,000.00 |
| Mar 31, 2024 | -898,000.00 |
| Dec 31, 2023 | 1.79 Mn |
| Dec 31, 2023 | 1.79 Mn |